- ... L, Wang JZ, Shan GL. Clinical efficacy and safety of huperzine A in treatment of mild to moderate Alzheimer ...
- ... Wang H, Wei ZH, et al. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: ...
- ... souvenaid versus placebo. 13.2.4.9.4. Huperzine A Very low- to low-quality evidence from ... with mild to moderate Alzheimer’s disease offered Huperzine A versus placebo or no intervention. Moderate-quality ...
- ... Souvenaid Cognition (post-intervention) ADCS-ADL (post-intervention) Huperzine A MMSE (post-intervention) ADL (post-intervention) BPSD ( ... 30 minutes long) Horvath 2013 Received a home safety toolkit, which included a booklet (keep the home ...
- ... Li WN, Yu HY (2011) The efficacy of Huperzine A in treating mild to moderate Data not ... Shi W, Chen XH (2013) Clinical study of huperzine A on patients with mild and moderate Alzheimer ...
- ... We found no eligible studies for Prevagen (apoaequorin), huperzine or phosphatidylserine. Our findings are mostly consistent with ... behavioral and psychological symptoms of dementia ( BPSD ), and safety? We identified several eligible trials that directly compared ...
- ... Liang XM, Juan W, et al. Treatment with Huperzine A improves cognition in vascular dementia patients. Cell ...
- ... interest (e.g., cannabinoids, ginseng, omega 3, gingko, huperzine A), a new comprehensive systematic review examining the ...